Blue Scorpion Venom: A New frontier in Pet Oncological Treatment - PTLF Pet life Pharmaceuticals

A new frontier in pet oncological treatment; based on blue scorpion venom, which has been used for years to to treat humans with cancer in many countries.


OTCQB:PTLF Petlife Pharmaceuticals, Inc.







Petlife is poised to change the paradigm of treatment in veterinary oncology. It is reported that over 50% of dogs and cats living past the age of 10 develop cancer. Last year in the U.S. approximately 13 million families had to face this diagnosis in their beloved companion animals. Our all natural "Vitalzul for Pets™ has a strong scientific basis for the treatment of cancer and offers an alternative to standard chemotherapy, surgery and other invasive treatment that are often as toxic as the cancer itself. Petlife's mission is to provide an affordable solution that also avoids the unfortunate and often deadly side effects of traditional treatment. Pet life Pharmaceuticals is introducing a new break through pet cancer drug that is anticipated to begin FDA trials this summer. The drug is an organic-all natural compound. The FDA trials are estimated to take no longer than 18-24 months. 




Vitalzul for Pets




  • New frontier in pet oncological treatment; based on blue scorpion venom, which has been used for years to to treat humans with cancer in many countries

  • Revolutionary new drug, with proven ability to reduce tumor size- no signs of toxicity or complications observed during clinical use.

  • Can be easily administered, has healthy profit margins, market acceptance will be quick, translating to high sales growth




  • Vitalzul™ for Pets ™ is a an innovative polarized, potentiated bio-active peptide extracted from the Blue Scorpion (Rhopularus Princeps) icon1 Induces apoptosis on a variety of cancer cells by a pattern of DNA fragmentation icon1 It is based on the same-patented formula of "Vitalzul" used for the treatment of cancer in humans but is amplified through polarization technology.




Products

Introducing a new generation of HP
(high potency) veterinary cancer medications and nutraceuticals







































TAG